You are here
Since October 2008, we have supported more than 145 studies, connecting over 106,000 volunteers with innovative research around the world. These research projects have studied everything from our microbiota to novel breast cancer genes. We have made a point to partner with researchers who are asking important questions that may help eradicate breast cancer.
While these research studies are always different, there is one common factor: our dedicated Army of Women members. With their help, the following supported studies completed enrollment:
Regular physical activity is beneficial for women who have been diagnosed with breast cancer, potentially reducing the likelihood of recurrence. Studies have also found exercise can help decrease fatigue, improve mood and cognition, and increase sleep quality. However, many women find it difficult to begin or maintain a regular physical activity program. A research team from UT Southwestern Medical Center investigated a new way to help breast cancer survivors increase their physical activity — a six-month education program, available in two Texas locations: Dallas (UT Southwestern) and Fort Worth (Moncrief Cancer Institute). The initial call to action was sent on October 10, 2018. The study was closed on March 11, 2020.
The BREAST-Q is a questionnaire used around the world in patient care and research. The BREAST-Q measures quality of life and breast satisfaction. In this study, researchers tested 5 new scales relevant to all breast cancer patients and 7 new scales for women who develop arm lymphedema. These new scales will make it possible for researchers and health care providers to better understand the impact of breast cancer and lymphedema on quality of life.
The initial Call to Action was sent in July of 2018. The researcher then expanded the study to include all women with any stage of breast cancer, with or without breast reconstruction. The study closed on January 3, 2020.
The purpose of this research is to learn how the results of your Oncotype Dx® test results affect your health-related quality of life; your feelings of distress, anxiety, depression, and fear; and your perceived risk of recurrence. The researchers will use these findings to develop a personalized symptom management program to help improve the quality of life of breast cancer survivors. The research team wanted to enroll up to 130 participants.
The initial Call to Action for this study was sent to AOW members on August 7, 2019 and the researchers closed enrollment on January 2, 2020. The AOW provided them with 138 women who were interested in enrolling in the study.
The purpose of this study is to develop and test a safe, effective, and individualized exercise, nutrition, and mindfulness program that can help survivors of early-stage breast cancer on an anti-estrogen therapy reduce bone loss. This new online program, called Thrivors™, provides instructions for home- or gym-based exercises, resources for nutrition and mindfulness, and educational content on the benefits of a healthy lifestyle after a cancer diagnosis. This study will compare participants' experiences using two different versions of the Thrivors™ program: ThrivorsBasic™ and Thrivors+BoneHealth(BH)™.
The initial Call to Action for this study was sent to AOW members on April 20, 2019 and the researchers closed enrollment in December of 2019. The AOW provided them with 189 women who were interested in enrolling in this study
The purpose of this study is to see how well two different types of group programs—mindfulness-meditation classes and survivorship education classes—meet the needs of young survivors. Up to 360 women were needed for this study.
The initial Call to Action for this study was sent to AOW members on May 3, 2017 and the researchers closed enrollment in August of 2019. The AOW provided them with 358 women who were interested in enrolling in the study.
The purpose of this study is to learn how two different medications affect the breast: an estrogen-free selective progesterone-receptor modulator called UPA vs. a low-dose oral contraceptive pill. This is a randomized, phase I clinical trial. Participants have a 50% chance of receiving the UPA pill, and 50% chance of receiving the low-dose oral contraceptive.
The initial Call to Action for this study was sent to AOW members on August 9, 2017 and the researchers closed enrollment in November of 2019. The AOW provided them with 13 women who were interested in enrolling in the study.
A research team at Johns Hopkins wanted to learn how to improve access to follow-up care for women who get an abnormal breast cancer screening result. To learn what care women do or don’t get, the research team had to recruit about 500 women who received abnormal results from a mammogram, breast MRI, or clinical breast exam or a diagnosis of breast cancer complete a 30-minute survey about their healthcare experiences.
The research team recruited for this study in July 2018 and enrolled more than 200 women. Most of the women who signed up to participate were White and heterosexual. To better assess healthcare experiences across populations, the research team then recruited participants from other racial / ethnic groups and sexual orientations. The call to action was sent out on July 18, 2018, and the study closed on November 8, 2019.
The purpose of this study was to better understand which factors women and men find most important as they consider different surgical treatment options. Researchers needed 500 women who had a single or double mastectomy after a breast cancer diagnosis.
The initial call to action was sent on June 27, 2018. The AOW provided them with 997 women who were interested in the study. The researchers will use what they learn to improve how health care providers approach shared decision-making with their breast cancer patients.
The purpose of this study was to learn about the best ways to improve access to breast cancer care and treatment for members of the Black LGBQ-SGL community. The research team wanted to enroll up to 30 participants for an in-depth phone interview about identities and healthcare experiences.
The initial Call to Action for this study was sent to AOW members on January 17, 2018 and the researchers closed enrollment on October 29, 2019. The AOW provided them with 6 women who were interested in enrolling in the study.
The goal of this study is to better understand what women are thinking about and feeling as they decide on their cancer treatments. The AOW provided the researchers with 219 women who were interested in participating. The results of this study may help researchers develop new interventions that may better assist women newly diagnosed with breast cancer with their treatment decisions.